ArticleBMJ case reports2024

Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma.

Santiago Sucre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.